Detalhe da pesquisa
1.
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.
Br J Haematol
; 197(1): 76-81, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34881427
2.
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial.
Blood Cancer J
; 11(6): 106, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083504
3.
Normal and malignant cells are homogeneously distributed in the bone marrow of children.
Leuk Lymphoma
; : 1-4, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587123